Redirecting to original paper in 30 seconds...
Click below to go immediately or wait for automatic redirect
📄 Abstract
Abstract: Bulk tissue RNA sequencing of heterogeneous samples provides averaged gene
expression profiles, obscuring cell type-specific dynamics. To address this, we
present a probabilistic hierarchical Bayesian model that deconvolves bulk
RNA-seq data into constituent cell-type expression profiles and proportions,
leveraging a high-resolution single-cell reference. We apply our model to human
endometrial tissue across the menstrual cycle, a context characterized by
dramatic hormone-driven cellular composition changes. Our extended framework
provides a principled inference of cell type proportions and cell-specific gene
expression changes across cycle phases. We demonstrate the model's structure,
priors, and inference strategy in detail, and we validate its performance with
simulations and comparisons to existing methods. The results reveal dynamic
shifts in epithelial, stromal, and immune cell fractions between menstrual
phases, and identify cell-type-specific differential gene expression associated
with endometrial function (e.g., decidualization markers in stromal cells
during the secretory phase). We further conduct robustness tests and show that
our Bayesian approach is resilient to reference mismatches and noise. Finally,
we discuss the biological significance of our findings, potential clinical
implications for fertility and endometrial disorders, and future directions,
including integration of spatial transcriptomics.
Authors (4)
Crystal Su
Kuai Yu
Mingyuan Shao
Daniel Bauer
Submitted
October 31, 2025
Key Contributions
This paper presents a novel hierarchical Bayesian model for deconvolving bulk RNA-seq data into cell-type-specific expression profiles and proportions, using a high-resolution single-cell reference. Applied to human endometrium across the menstrual cycle, it reveals dynamic cellular shifts and cell-type-specific gene expression changes, providing a principled inference method.
Business Value
Enables deeper understanding of tissue biology and disease mechanisms, potentially leading to new diagnostic markers or therapeutic targets in areas like reproductive health.